Effects of obesity on weight-bearing versus weight-supported exercise testing in patients with COPD

Respirology

Volumn 21, Issue 3, 2016, Pages 483-488

  Maatman, Robbert C ^a   Spruit, Martijn A ^a   Van Melick, Paula P ^a   Peeters, Jos P I ^a   Rutten, Erica P A ^a   Vanfleteren, Lowie E G W ^a,b   Wouters, Emiel F M ^a,b   Franssen, Frits M E ^a,b  

^a CIRO+   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

chronic obstructive pulmonary disease; obesity; rehabilitation; weight bearing exercise; weight supported exercise

Indexed keywords

ADULT; ARTICLE; BODY MASS; CARDIOPULMONARY EXERCISE TEST; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; DYSPNEA; EXERCISE TEST; EXERCISE TOLERANCE; FATIGUE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LEG FATIGUE; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PULMONARY REHABILITATION; RETROSPECTIVE STUDY; SCORING SYSTEM; WALK TEST; WEIGHT BEARING EXERCISE TESTING; WEIGHT SUPPORTED EXERCISE TESTING; AGED; COMPLICATION; LUNG; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; WEIGHT BEARING;

AGED; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; OBESITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; WEIGHT-BEARING;

EID: 84949818269     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12700     Document Type: Article

References (31)

1. WHO. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organization technical report series. 2000; Vol. 894: i-xii, 1-253.
2. Steuten LM, Creutzberg EC, Vrijhoef HJ, Wouters EF,. COPD as a multicomponent disease: inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary care. Prim. Care Respir. J. 2006; 15: 84-91.
3. Schokker DF, Visscher TL, Nooyens AC, van Baak MA, Seidell JC,. Prevalence of overweight and obesity in the Netherlands. Obes. Rev. 2007; 8: 101-108.
4. Vanfleteren LE, Franssen FM, Wesseling G, Wouters EF,. The prevalence of chronic obstructive pulmonary disease in Maastricht, the Netherlands. Respir. Med. 2012; 106: 871-874.
5. Vozoris NT, O'Donnell DE,. Prevalence, risk factors, activity limitation and health care utilization of an obese, population-based sample with chronic obstructive pulmonary disease. Can. Respir. J. 2012; 19: e18-24.
6. Salome CM, King GG, Berend N,. Physiology of obesity and effects on lung function. J. Appl. Physiol. 2010; 108: 206-211.
7. Sin DD, Jones RL, Man SF,. Obesity is a risk factor for dyspnea but not for airflow obstruction. Arch. Intern. Med. 2002; 162: 1477-1481.
8. Cecere LM, Littman AJ, Slatore CG, Udris EM, Bryson CL, Boyko EJ, Pierson DJ, Au DH,. Obesity and COPD: associated symptoms, health-related quality of life, and medication use. COPD 2011; 8: 275-284.
9. Ramachandran K, McCusker C, Connors M, Zuwallack R, Lahiri B,. The influence of obesity on pulmonary rehabilitation outcomes in patients with COPD. Chron. Respir. Dis. 2008; 5: 205-209.
10. Agusti A, Edwards LD, Rennard SI, MacNee W, Tal-Singer R, Miller BE, Vestbo J, Lomas DA, Calverley PM, Wouters E, et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS ONE 2012; 7: e37483.
11. Vanfleteren LE, Spruit MA, Groenen M, Gaffron S, van Empel VP, Bruijnzeel PL, Rutten EP, Op 't Roodt J, Wouters EF, Franssen FM,. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2013; 187: 728-735.
12. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP,. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1999; 160: 1856-1861.
13. O'Donnell DE, Deesomchok A, Lam YM, Guenette JA, Amornputtisathaporn N, Forkert L, Webb KA,. Effects of body mass index on static lung volumes in patients with airway obstruction. Chest 2011; 140: 461-468.
14. Ora J, Laveneziana P, Ofir D, Deesomchok A, Webb KA, O'Donnell DE,. Combined effects of obesity and COPD on dyspnea and exercise tolerance. Am. J. Respir. Crit. Care Med. 2009; 180: 964-971.
15. Bautista J, Ehsan M, Normandin E, Zuwallack R, Lahiri B,. Physiologic responses during the six minute walk test in obese and non-obese COPD patients. Respir. Med. 2011; 105: 1189-1194.
16. Ciavaglia CE, Guenette JA, Ora J, Webb KA, Neder JA, O'Donnell DE,. Does exercise test modality influence dyspnoea perception in obese patients with COPD? Eur. Respir. J. 2014; 43: 1621-1630.
17. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 2013; 187: 347-365.
18. Spruit MA, Vanderhoven-Augustin I, Janssen PP, Wouters EF,. Integration of pulmonary rehabilitation in COPD. Lancet 2008; 371: 12-13.
19. Coin A, Sergi G, Minicuci N, Giannini S, Barbiero E, Manzato E, Pedrazzoni M, Minisola S, Rossini M, Del Puente A, et al. Fat-free mass and fat mass reference values by dual-energy X-ray absorptiometry (DEXA) in a 20-80 year-old Italian population. Clin. Nutr. 2008; 27: 87-94.
20. ATS/ACCP. ATS/ACCP statement on cardiopulmonary exercise testing. Am. J. Respir. Crit. Care Med. 2003; 167: 211-277.
21. Wasserman K, Hansen JE, Sue DY, Whipp BJ, Casaburi R,. Principles of Exercise Testing and Interpretation, 2nd edn. Lea & Febiger, Philadelphia, PA, 1994. 480 p.
22. Carter R, Peavler M, Zinkgraf S, Williams J, Fields S,. Predicting maximal exercise ventilation in patients with chronic obstructive pulmonary disease. Chest 1987; 92: 253-259.
23. Borg GA,. Psychophysical bases of perceived exertion. Med. Sci. Sports Exerc. 1982; 14: 377-381.
24. Hernandes NA, Wouters EF, Meijer K, Annegarn J, Pitta F, Spruit MA,. Reproducibility of 6-min walking test in patients with COPD. Eur. Respir. J. 2011; 38: 261-267.
25. Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, McCormack MC, Carlin BW, Sciurba FC, Pitta F, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur. Respir. J. 2014; 44: 1428-1446.
26. Troosters T, Gosselink R, Decramer M,. Six minute walking distance in healthy elderly subjects. Eur. Respir. J. 1999; 14: 270-274.
27. Killian KJ, Summers E, Jones NL, Campbell EJ,. Dyspnea and leg effort during incremental cycle ergometry. Am. Rev. Respir. Dis. 1992; 145: 1339-1345.
28. van de Bool C, Rutten EP, Franssen FM, Wouters EF, Schols AM,. Antagonistic implications of sarcopenia and abdominal obesity on physical performance in COPD. Eur. Respir. J. 2015; 46: 336-345.
29. Greening NJ, Evans RA, Williams JE, Green RH, Singh SJ, Steiner MC,. Does body mass index influence the outcomes of a Waking-based pulmonary rehabilitation programme in COPD? Chron. Respir. Dis. 2012; 9: 99-106.
30. Mesquita R, Vanfleteren LE, Franssen FM, Sarv J, Taib Z, Groenen MT, Gaffron S, Bruijnzeel PL, Pitta F, Wouters EF, et al. Objectively identified comorbidities in chronic obstructive pulmonary disease: impact on pulmonary rehabilitation outcomes. Eur. Respir. J. 2015; 46: 545-548.
31. McNamara RJ, McKeough ZJ, McKenzie DK, Alison JA,. Water-based exercise in COPD with physical co-morbidities: a randomised controlled trial. Eur. Respir. J. 2012; 41: 1284-1291.